ConductScience.org, home

Trial · NCT02061540

Results by group23

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Maralixibat (LUM001) 1 mg1participant
Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Maralixibat (LUM001) 2.5 mg2participant
Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Maralixibat (LUM001) 5 mg2participant
Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Maralixibat (LUM001) 7.5 mg1participant
Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Maralixibat (LUM001) 10 mg19participant
Change From Baseline in Fasting Serum Bile Acid Level at Week 14Maralixibat (LUM001)Baseline38.941Standard Deviation 38.6614micromoles per liter
Change From Baseline in Fasting Serum Bile Acid Level at Week 14Maralixibat (LUM001)Change From Baseline-14.841Standard Deviation 31.3709micromoles per liter
Change From Baseline in Liver Enzyme Levels in SerumMaralixibat (LUM001)ALT: Baseline108.5Standard Deviation 78.95units per liter (U/L)
Change From Baseline in Liver Enzyme Levels in SerumMaralixibat (LUM001)ALT: Change From Baseline10.5Standard Deviation 63.07units per liter (U/L)
Change From Baseline in Liver Enzyme Levels in SerumMaralixibat (LUM001)AST: Baseline88.3Standard Deviation 43.70units per liter (U/L)
Change From Baseline in Liver Enzyme Levels in SerumMaralixibat (LUM001)AST: Change From Baseline11.7Standard Deviation 34.14units per liter (U/L)
Change From Baseline in Liver Enzyme Levels in SerumMaralixibat (LUM001)ALP: Baseline471.6Standard Deviation 316.93units per liter (U/L)
Change From Baseline in Liver Enzyme Levels in SerumMaralixibat (LUM001)ALP: Change From Baseline36.7Standard Deviation 170.87units per liter (U/L)
Change From Baseline in Bilirubin Levels at Week 14Maralixibat (LUM001)Total Bilirubin Level: Baseline1.22Standard Deviation 0.775milligram per deciliter (mg/dL)
Change From Baseline in Bilirubin Levels at Week 14Maralixibat (LUM001)Total Bilirubin Level: Change From Baseline0.24Standard Deviation 0.666milligram per deciliter (mg/dL)
Change From Baseline in Bilirubin Levels at Week 14Maralixibat (LUM001)Conjugated Bilirubin Level: Baseline0.60Standard Deviation 0.510milligram per deciliter (mg/dL)
Change From Baseline in Bilirubin Levels at Week 14Maralixibat (LUM001)Conjugated Bilirubin Level: Change From Baseline0.19Standard Deviation 0.450milligram per deciliter (mg/dL)
Change From Baseline in Pruritus as Measured by Adult Itch Reported Outcome (ItchRO) Weekly Sum ScoreMaralixibat (LUM001)Baseline15.00Standard Deviation 18.735units on scale
Change From Baseline in Pruritus as Measured by Adult Itch Reported Outcome (ItchRO) Weekly Sum ScoreMaralixibat (LUM001)Change From Baseline-7.67Standard Deviation 16.326units on scale
Change From Baseline for Other Biochemical Markers of Cholestasis: Total Cholesterol, Low Density Lipoprotein CholesterolMaralixibat (LUM001)TC Level: Baseline213.0Standard Deviation 50.62mg/dL

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02061540/results